Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial

Table 3

Pseudophakic patients: descriptive statistics.

Group I age	Group II age	value	Number of patients	Group I	Group II
69.21 ± 5.32 years	65.12 ± 4.3 years	0.48	N = patients	8	12
Parameter	Preoperative value		value	Postoperative value		value
Groups	Group I	Group II		Group I	Group II
IOP (mm Hg)	25.42 ± 5.20	28.6 ± 6.90	0.62	13.34 ± 2.34	14.10 ± 3.20	0.83
CDVA (logMAR)	0.34 ± 0.31	0.34 ± 0.24	0.94	0.36 ± 0.25	0.30 ± 0.26	0.71
Diurnal IOP	3.11 ± 2.11	1.53 ± 1.42	0.91	1.33 ± 0.69	1.82 ± 1.0	0.78
Number of medications	2.96 ± 1.21	2.82 ± 1.6	0.86	0.05 ± 0.03	0.08 ± 0.09	0.90
Duration of medicine use	4.14 ± 4.0 years	5.75 ± 4.15 years	0.43

Group I: 4 males and 4 females; Group II: 7 males and 5 females.